XBiotech Inc. XBIT
XBiotech Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | 83.8% | 68.4% | 21.5% | — | — | — | — |
| Operating margin | — | — | — | -860.1% | -136.4% | -41.5% | — | — | — | — |
| Net margin | — | — | — | -820.4% | -94.7% | -25.5% | — | — | — | — |
| FCF margin | — | — | — | -384.3% | 358.4% | -156.5% | — | — | — | — |
| Return on assets | -30.3% | -19.4% | -10.8% | -13.4% | -6.3% | -3.2% | 81.9% | -47.7% | -52.6% | -78.7% |
| Return on equity | -32.4% | -21.1% | -11.2% | -13.7% | -6.5% | -3.2% | 88.5% | -51.1% | -55.1% | -89.3% |
| Current ratio | 16.01 | 11.56 | 33.07 | 54.07 | 71.49 | 81.80 | 11.90 | 5.78 | 11.94 | 4.64 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.